its	O
largest	O
holding	O
consisted	O
of	O
zu-23s	product-weapon
(	O
which	O
it	O
can	O
manufacture	O
)	O
.	O

john	building-hospital
peter	building-hospital
smith	building-hospital
hospital	building-hospital
provides	O
emergency	O
services	O
and	O
trauma	O
care	O
.	O

despite	O
playing	O
a	O
style	O
more	O
attuned	O
to	O
fast	O
surfaces	O
,	O
his	O
strong	O
showing	O
at	O
the	O
2008	event-sportsevent
french	event-sportsevent
open	event-sportsevent
,	O
2010	event-sportsevent
rome	event-sportsevent
masters	event-sportsevent
and	O
2014	event-sportsevent
french	event-sportsevent
open	event-sportsevent
are	O
attributed	O
to	O
his	O
powerful	O
and	O
flat	O
strokes	O
which	O
can	O
play	O
through	O
the	O
surface	O
.	O

the	O
1972	O
summer	event-sportsevent
olympics	event-sportsevent
was	O
the	O
last	O
major	O
outing	O
for	O
her	O
and	O
she	O
reached	O
the	O
final	O
,	O
although	O
an	O
injury	O
sustained	O
in	O
the	O
semi-final	O
meant	O
she	O
finished	O
last	O
in	O
the	O
event	O
final	O
and	O
subsequently	O
retired	O
at	O
age	O
29	O
.	O

the	O
location	O
of	O
the	O
indian	building-theater
hills	building-theater
theater	building-theater
now	O
serves	O
as	O
a	O
parking	O
lot	O
.	O

armament	O
was	O
one	O
m1919	product-weapon
browning	product-weapon
mg	product-weapon
and	O
one	O
m2	product-weapon
browning	product-weapon
mg	product-weapon
mounted	O
in	O
the	O
nose	O
.	O

twelve	O
teams	O
competed	O
in	O
the	O
2018–19	O
nifl	event-sportsevent
premiership	event-sportsevent
,	O
ten	O
of	O
which	O
retained	O
their	O
premiership	O
status	O
from	O
the	O
previous	O
season	O
.	O

asp	product-weapon
21	product-weapon
inch	product-weapon
telescopic	product-weapon
baton	product-weapon
,	O
saf-lok	product-weapon
mk5	product-weapon
hinged	product-weapon
handcuffs	product-weapon
,	O
oleoresin	product-weapon
capsicum	product-weapon
(	product-weapon
oc	product-weapon
)	product-weapon
spray	product-weapon
.	O

in	O
2003	O
she	O
was	O
appointed	O
to	O
the	O
st.	building-hospital
james	building-hospital
's	building-hospital
hospital	building-hospital
institute	building-hospital
of	building-hospital
molecular	building-hospital
medicine	building-hospital
.	O

she	O
returned	O
to	O
the	O
production	O
,	O
which	O
had	O
then	O
moved	O
to	O
the	O
gielgud	building-theater
theatre	building-theater
,	O
in	O
december	O
2008	O
and	O
continued	O
playing	O
her	O
roles	O
until	O
3	O
october	O
2009	O
.	O

st	building-hospital
john	building-hospital
of	building-hospital
god	building-hospital
health	building-hospital
care	building-hospital
acquired	O
mt	building-hospital
alvernia	building-hospital
mercy	building-hospital
hospital	building-hospital
in	O
february	O
2005	O
,	O
renaming	O
it	O
st	building-hospital
john	building-hospital
of	building-hospital
god	building-hospital
bendigo	building-hospital
hospital	building-hospital
.	O

nodules	other-medical
that	O
grow	O
larger	O
or	O
produce	O
symptoms	O
may	O
eventually	O
need	O
medical	O
care	O
.	O

it	O
transferred	O
to	O
the	O
gielgud	building-theater
theatre	building-theater
in	O
the	O
west	O
end	O
on	O
23	O
june	O
,	O
where	O
it	O
ran	O
until	O
5	O
january	O
2013	O
.	O

the	O
drug	O
is	O
also	O
not	O
associated	O
with	O
weight	O
gain	O
,	O
in	O
contrast	O
to	O
many	O
other	O
tcas	other-medical
.	O

a	O
pooled	O
analysis	O
of	O
randomized	O
,	O
controlled	O
studies	O
of	O
meloxicam	other-medical
therapy	O
of	O
up	O
to	O
60	O
days	O
duration	O
found	O
that	O
meloxicam	other-medical
was	O
associated	O
with	O
a	O
statistically	O
significantly	O
lower	O
number	O
of	O
thromboembolic	other-medical
complications	other-medical
than	O
the	O
nsaid	other-medical
diclofenac	other-medical
(	O
0.2	O
%	O
versus	O
0.8	O
%	O
respectively	O
)	O
but	O
a	O
similar	O
incidence	O
of	O
thromboembolic	other-medical
events	O
to	O
naproxen	other-medical
and	O
piroxicam	other-medical
.	O

the	O
théâtre	building-theater
royal	building-theater
was	O
renamed	O
“	O
théâtre	building-theater
municipal	building-theater
”	O
in	O
1870	O
.	O

